Fecal microbiota transplantation may improve immunotherapy-related colitis

Targeting the gut microbiome with fecal microbiota transplantation (FMT) may help cancer patients with immunotherapy-related colitis avoid the need for steroids and other immunosuppressive treatments, according to researchers at The University of Texas MD Anderson Cancer Center.